Varfaj Fatbardha, Neuberg Julie, Jenkins P Vincent, Wakabayashi Hironao, Fay Philip J
Department of Biochemistry and Biophysics, University of Rochester School of Medicine, 601 Elmwood Avenue, Rochester, NY 14642, USA.
Biochem J. 2006 Jun 1;396(2):355-62. doi: 10.1042/BJ20060117.
APC (activated Protein C) inactivates human Factor VIIIa following cleavage at residues Arg336 and Arg562 within the A1 and A2 subunits respectively. The role of the P1 arginine in APC-catalysed inactivation of Factor VIIIa was examined by employing recombinant Factor VIIIa molecules where residues 336 and 562 were replaced with alanine and/or glutamine. Stably expressed Factor VIII proteins were activated by thrombin and resultant Factor VIIIa was reacted at high concentration with APC to minimize cofactor inactivation due to A2 subunit dissociation. APC cleaved wild-type Factor VIIIa at the A1 site with a rate approximately 25-fold greater than that for the A2 site. A1 mutants R336A and R336Q were inactivated approximately 9-fold slower than wild-type Factor VIIIa, whereas the A2 mutant R562A was inactivated approximately 2-fold slower. No cleavage at the mutated sites was observed. Taken together, these results suggested that cleavage at the A1 site was the dominant mechanism for Factor VIIIa inactivation catalysed by the proteinase. On the basis of cleavage at Arg336, a K(m) value for wild-type Factor VIIIa of 102 nM was determined, and this value was significantly greater than K(i) values (approximately 9-18 nM) obtained for an R336Q/R562Q Factor VIIIa. Furthermore, evaluation of a series of cluster mutants in the C-terminal region of the A1 subunit revealed a role for acidic residues in segment 341-345 in the APC-catalysed proteolysis of Arg336. Thus, while P1 residues contribute to catalytic efficiency, residues removed from these sites make a primary contribution to the overall binding of APC to Factor VIIIa.
活化蛋白C(APC)分别在A1和A2亚基内的精氨酸336和精氨酸562位点切割后,可使人类凝血因子VIIIa失活。通过使用重组凝血因子VIIIa分子(其中336和562位点被丙氨酸和/或谷氨酰胺取代),研究了P1精氨酸在APC催化的凝血因子VIIIa失活中的作用。稳定表达的凝血因子VIII蛋白被凝血酶激活,所得的凝血因子VIIIa与APC在高浓度下反应,以尽量减少由于A2亚基解离导致的辅因子失活。APC在A1位点切割野生型凝血因子VIIIa的速率比在A2位点切割的速率大约高25倍。A1突变体R336A和R336Q的失活速度比野生型凝血因子VIIIa慢约9倍,而A2突变体R562A的失活速度慢约2倍。在突变位点未观察到切割。综上所述,这些结果表明,在A1位点的切割是蛋白酶催化凝血因子VIIIa失活的主要机制。基于在精氨酸336处的切割,确定野生型凝血因子VIIIa的K(m)值为102 nM,该值显著高于R336Q/R562Q凝血因子VIIIa的K(i)值(约9 - 18 nM)。此外,对A1亚基C末端区域的一系列簇状突变体的评估揭示了341 - 345片段中的酸性残基在APC催化的精氨酸336蛋白水解中的作用。因此,虽然P1残基有助于催化效率,但从这些位点去除的残基对APC与凝血因子VIIIa的整体结合起主要作用。